Week 21 Partial Veterinary Drug Quotes 2
Aminoglycosides
Monosulfate kanamycin, the market inquiry is small, the transaction volume is small, the market price is 305, the actual transaction price is negotiable
Neomycin sulfate, more inquiries, transaction price 145-154
Spectinomycin hydrochloride, the supply is less, the market is stable, the market price is around 555
Gentamicin sulfate, the price is high, the market is struggling, and the Asia-Pacific Trading and Data Analysis Center will pay close attention. Market Quote 1520
Streptomycin sulfate, stable supply, low demand, market quotation 266-285
Apramycin sulfate, there is a small demand in the market, the price will follow the market, and the quotation should be less than 200; manufacturers: Zhejiang Puluo, Shandong Qifa, Hongtianwei, Henan Renhua
Sulfonamides
In recent years, the active products of sulfamethoxazole (sodium), sulfachlorpyrazine (sodium), sulfachlordazine (sodium), and trimethoprim are generally at high levels. Due to the restricted end use, the total market volume has declined, and the market fluctuations have been small. , intervention needs to be cautious.
Sulfadiazine (sodium), stable transaction, balanced market supply and demand, quotation 240-248
Sulfamethazine (sodium), stable and weak, the price follows the market, the price is 115, and the price in the same period in 2020 and 2021 is 98
Sulfamethoxazole (sodium), the price is stable 130-140
Sulfa-paramethoxine (sodium), the market is shrinking, there are few inquiries, the market price is 340
Sulfamethoxazole (sodium), the supply is stable, the price is slightly lowered, the quotation is 300-310
Sulfachlorpyrazine sodium, stable, the price is around 330, the price in the same period last year was 352, the price in the same period in 2020 was 375, and the price in the same period in 2019 was 295. The price has changed greatly
Sulfachlordazine sodium, fluctuated slightly, running weakly, the market price is around 290
Sulfaquinoxaline sodium, the price is adjusted within a narrow range, the market price is 340
The demand for trimethoprim and trimethoprim lactate is relatively stable. The market price of trimethoprim lactate is 186, and the market price of trimethoprim is 238. After a short surge in October last year, the current price is stable and strong.
Dimethoprim, stable operation, small transaction volume, quotation 390
Quinolones
Enrofloxacin and enrofloxacin hydrochloride are running at high levels, affected by aquaculture in summer, and the market volume has increased. The market price of enrofloxacin is close to 260; the market price of enrofloxacin hydrochloride is 255
Ciprofloxacin lactate, ciprofloxacin hydrochloride, market price 252
Sarafloxacin hydrochloride, the price is high and stable 498
Marbofloxacin, smooth operation
Antiparasitic
Diclazuli, slightly fluctuated, the market price is 1640
Ivermectin, running smoothly, price 1380-1462
Toltrazuril, the market is picking up, at a low level in recent years, the price is 1450-1580
Abamectin, the price is stable, the market amount is not large, the price is 810
Albendazole, low volatility, sufficient supply from manufacturers, market price 158-165
Fenbendazole, the supply is less, the demand is not big, the market price is 340
Levamisole hydrochloride, running at a high level, the market price is around 465
Metronidazole, the supply is tight, the inquiries are increasing, and the market price is 89
Dimetridazole, the supply is tight, the price is firm, the market price is around 120
Praziquantel, strong run, market price 615
Cypromazine, running smoothly
Antipyretic, Analgesic, Asthma, Improve Immunity
Flunixin meglumine, stable, the market demand is not strong, the market price is around 850
Analgin, the trading volume is rising, and the Asia-Pacific exchange and data analysis center will pay close attention. Quote around 90
Acetaminophen, weak running, shrinking shipments, market price 66
Carbasalate calcium, a slight correction, the quotation is 38-52, the market supply is sufficient, and the price is negotiable
Taurine, low and stable, the price is around 26
Aminophylline, tight supply
Aminopyrine, the market is stable
Aspirin, stable, market quote 28
Veterinary drug excipients and others
Acemequine, raw materials rose, profits of manufacturers fell, the market may strengthen after the market picks up, the market price is 70-75 injection grade 110
Sodium salicylate, rising slightly, market price 32
Sodium Citrate, Shock Finish, Quote 20.5
Sodium camphorsulfonate, stable, the market price is around 80
Chlormin, the recent demand is less, the price remains stable, the market price is around 210
Glucose, the transaction is stable, the tonnage price range is 5200-6800
Jiayi powder, starch, stable transaction
Beta cyclodextrin, stable situation, market price 22-36
vitamins
VC, the quotation is generally lowered. The current quotation is about 30 for feed grade and 40 for pharmaceutical grade.
VA, the manufacturer plans to stop production for maintenance in June, the mixture is 210, and the water-soluble 230
VB1, weak operation, high market attention, nitric acid 155, hydrochloric acid 235
VB2, running smoothly, market quotes 80%115, 98%380
VB6, supply and demand balance, the market is stable, the quotation is around 128
VB12, the demand is weak, a small amount is purchased on demand, the price fluctuates at a low level, and the market price is around 135
VD3, overall downward, partial consolidation, mix 86, water solubility 104
VE, overall stable, increased inquiries, ingredients 92, water solubility 108
VK3, some manufacturers stopped reporting and signing, and the market supply decreased
Calcium pantothenate, rising, market quote 337
Niacinamide, down slightly, currently quoted at 55
2% biotin, the manufacturer has lowered the ex-factory price, and the market price is around 52
Folic acid, fell slightly, quoted around 270
Looking for chemical products? Let suppliers reach out to you!
2026-07-08
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Market Analysis of Domestic Veterinary Drug Raw Materials in the 34th Week of 2022
-
The Veterinary Drug Industry is Facing a Period of Opportunity for Change, and Leading Animal Health Companies are Expected to Grow Rapidly
-
Analysis of China's Veterinary Drug Raw Material Market in the 32nd Week of 2022(2)
-
Analysis of China's Veterinary Drug Raw Material Market in the 32nd Week of 2022(1)
-
Analysis of the Domestic Veterinary Drug Raw Material Market in the 28th Week of 2022
-
Analysis of the Domestic Veterinary Drug Raw Material Market in the 28th Week of 2022
-
Analysis of The Veterinary Drug Raw Material Market in the 21st Week
-
Market Analysis of Veterinary Drug Raw Materials
-
Continue to Crack Down On The Illegal Use of Veterinary Drugs And Additives in 2022
-
Analysis of Aminoglycosides Market
Recommend Reading
-
Eisai Pharma Unveils Bold Plan: $100 Million Global Center Set to Transform Visakhapatnam Now
-
Over 70% of Patients Find Relief in Bayer’s New Breakthrough Drug for Breast Cancer Menopause Symptoms
-
Novo Nordisk Submits Higher Dose of Wegovy One in Three Achieves Over 25 Percent Weight Loss
-
Lupin Secures Tentative U.S. Approval for Its Multiple Sclerosis Tablet
-
API Supplier Audits Move to the Center of Pharma Supply Resilience
-
Sodium Nitrate: Fertilizer, Food Preservative, and Chemical Properties
-
Arkema Continues to Increase Investment in Singapore, Investing $20 Million to Build a Transparent Polyamide Plant
-
DKSH Expands Partnership with Assessa to Distribute Botanical Ingredients Across China
-
Surge by 4,000 CNY/ton! Is the melamine market in China showing signs of peaking?
-
DGT to Acquire Whale Cloud for Control in 5.09 Billion Yuan Expansion with 150% Profit Surge